Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Site Trial of Tirzepatide for Smoking Cessation

NCT07602699 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT07602699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07602699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Site Trial of Tirzepatide for Smoking Cessation
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Recruiting
Start date
June 5, 2026
Completion date
September 30, 2028
Enrollment
300 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

smoking behaviors, smoking cessation